BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18064414)

  • 21. Understanding the molecular mechanism underlying the presynaptic toxicity of secreted phospholipases A(2): an update.
    Šribar J; Oberčkal J; Križaj I
    Toxicon; 2014 Oct; 89():9-16. PubMed ID: 25009088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into clostridial neurotoxin-SNARE interactions.
    Breidenbach MA; Brunger AT
    Trends Mol Med; 2005 Aug; 11(8):377-81. PubMed ID: 16006188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromuscular action of venom from the South American colubrid snake Philodryas patagoniensis.
    Carreiro da Costa RS; Prudêncio L; Ferrari EF; Souza GH; de Mello SM; Prianti Júnior AC; Ribeiro W; Zamunér SR; Hyslop S; Cogo JC
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Jul; 148(1):31-8. PubMed ID: 18455482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects and mechanisms of polypeptide neurotoxins that act presynaptically.
    Howard BD; Gundersen CB
    Annu Rev Pharmacol Toxicol; 1980; 20():307-36. PubMed ID: 6247959
    [No Abstract]   [Full Text] [Related]  

  • 25. Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins.
    Johnson EA
    Annu Rev Microbiol; 1999; 53():551-75. PubMed ID: 10547701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the site at which phospholipase A2 neurotoxins localize to produce their neuromuscular blocking effects.
    Simpson LL; Lautenslager GT; Kaiser II; Middlebrook JL
    Toxicon; 1993 Jan; 31(1):13-26. PubMed ID: 8446959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calpains participate in nerve terminal degeneration induced by spider and snake presynaptic neurotoxins.
    Duregotti E; Tedesco E; Montecucco C; Rigoni M
    Toxicon; 2013 Mar; 64():20-8. PubMed ID: 23266309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular mechanisms underlying the neuromuscular toxicity of Clostridium toxins].
    Tashima Z; Alkalay M
    Harefuah; 1999 May; 136(10):794-9. PubMed ID: 10955116
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of type a botulinum toxin products in clinical use.
    Pickett A; Caird D
    J Clin Pharm Ther; 2008 Jun; 33(3):327-8. PubMed ID: 18452421
    [No Abstract]   [Full Text] [Related]  

  • 30. Isolation and characterization of rufoxin, a novel protein exhibiting neurotoxicity from venom of the psammophiine, Rhamphiophis oxyrhynchus (Rufous beaked snake).
    Lumsden NG; Banerjee Y; Kini RM; Kuruppu S; Hodgson WC
    Neuropharmacology; 2007 Mar; 52(4):1065-70. PubMed ID: 17194464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain.
    Chaddock JA; Purkiss JR; Alexander FC; Doward S; Fooks SJ; Friis LM; Hall YH; Kirby ER; Leeds N; Moulsdale HJ; Dickenson A; Green GM; Rahman W; Suzuki R; Duggan MJ; Quinn CP; Shone CC; Foster KA
    Mov Disord; 2004 Mar; 19 Suppl 8():S42-7. PubMed ID: 15027053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum neurotoxin: the ugly duckling.
    Koussoulakos S
    Eur Neurol; 2009; 61(6):331-42. PubMed ID: 19365125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The structure and mechanism of action of clostridial neurotoxins].
    Parasion S; Bartoszcze M; Gryko R
    Przegl Epidemiol; 2007; 61(3):519-27. PubMed ID: 18069389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium overload in nerve terminals of cultured neurons intoxicated by alpha-latrotoxin and snake PLA2 neurotoxins.
    Tedesco E; Rigoni M; Caccin P; Grishin E; Rossetto O; Montecucco C
    Toxicon; 2009 Aug; 54(2):138-44. PubMed ID: 19341756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The analgesic potential of clostridial neurotoxin derivatives.
    Foster KA
    Expert Opin Investig Drugs; 2004 Nov; 13(11):1437-43. PubMed ID: 15500391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Snake postsynaptic neurotoxins: gene structure, phylogeny and applications in research and therapy.
    Phui Yee JS; Nanling G; Afifiyan F; Donghui M; Siew Lay P; Armugam A; Jeyaseelan K
    Biochimie; 2004 Feb; 86(2):137-49. PubMed ID: 15016453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterisation of a neurotoxin from the venom of Boiga dendrophila (mangrove catsnake).
    Lumsden NG; Fry BG; Ventura S; Kini RM; Hodgson WC
    Toxicon; 2005 Mar; 45(3):329-34. PubMed ID: 15683871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presynaptic action of crotoxin at the murine neuromuscular junction [proceedings].
    Hawgood BJ; Smith J
    J Physiol; 1977 Mar; 266(1):91P-92P. PubMed ID: 853444
    [No Abstract]   [Full Text] [Related]  

  • 39. Recent advances in chemistry and pharmacology of snake toxins.
    Lee CY
    Adv Cytopharmacol; 1979; 3():1-16. PubMed ID: 157674
    [No Abstract]   [Full Text] [Related]  

  • 40. Binding to the high-affinity M-type receptor for secreted phospholipases A(2) is not obligatory for the presynaptic neurotoxicity of ammodytoxin A.
    Prijatelj P; Vardjan N; Rowan EG; Krizaj I; Pungercar J
    Biochimie; 2006 Oct; 88(10):1425-33. PubMed ID: 16815622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.